Literature DB >> 20622929

Discussion on "A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials" by Elena M. Buzaianu and Pinyuen Chen.

Peter F Thall1.   

Abstract

Buzaianu and Chen apply strong curtailment to modify the two-stage select-and-test clinical trial design proposed by Thall et al. (1988). The modification reduces the expected sample size while maintaining overall power but requires continuous monitoring in stage 1. I will review the history of this type of design and discuss practical issues related to the use of strong curtailment that arise in trial conduct.

Entities:  

Year:  2009        PMID: 20622929      PMCID: PMC2900801          DOI: 10.1080/07474940802619170

Source DB:  PubMed          Journal:  Seq Anal        ISSN: 0747-4946            Impact factor:   0.927


  7 in total

1.  Sequential designs for phase III clinical trials incorporating treatment selection.

Authors:  Nigel Stallard; Susan Todd
Journal:  Stat Med       Date:  2003-03-15       Impact factor: 2.373

2.  Seamlessly expanding a randomized phase II trial to phase III.

Authors:  Lurdes Y T Inoue; Peter F Thall; Donald A Berry
Journal:  Biometrics       Date:  2002-12       Impact factor: 2.571

3.  An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several.

Authors:  Patrick J Kelly; Nigel Stallard; Susan Todd
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

Review 4.  A review of phase 2-3 clinical trial designs.

Authors:  Peter F Thall
Journal:  Lifetime Data Anal       Date:  2007-09-02       Impact factor: 1.588

5.  Randomized phase II clinical trials.

Authors:  R Simon; R E Wittes; S S Ellenberg
Journal:  Cancer Treat Rep       Date:  1985-12

6.  Accrual strategies for phase I trials with delayed patient outcome.

Authors:  P F Thall; J J Lee; C H Tseng; E H Estey
Journal:  Stat Med       Date:  1999-05-30       Impact factor: 2.373

7.  A design for phase II testing of anticancer agents within a phase III clinical trial.

Authors:  D J Schaid; J N Ingle; S Wieand; D L Ahmann
Journal:  Control Clin Trials       Date:  1988-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.